With the exception of high tumor grade and HER2 protein overexpression, which were more common in the E-T-CMF arm, basic clinicopathological characteristics were well balanced when the 352 analyzed patients were stratified by adjuvant chemotherapy arm (Table 2). This evidence concerns the gene ERBB2 and neoplasm.